However, in administrative data, coding errors may occur and comorbidities often not relevant to reimbursement, such as obesity, are possibly underreported
Meanwhile, the company is gearing up for the launch of new manufacturing plants in North Carolina and Germany, which are slated to become operational by the end of the year and in 2027, respectively
Disclaimer: This article is intended for licensed medical professionals
primaquine, sulfamethoxazole, quinolones, dapsone, and nitrofurantoin)
Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population